Compare SpaceX (SPCX) vs Tenet Healthcare Corporation (THC) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
SpaceX vs Tenet Healthcare Corporation — how do they compare? SpaceX trades at $134.96 (market cap $1.83T), while Tenet Healthcare Corporation trades at $259.45 (market cap $20.93B). The key difference: SpaceX is far larger — about 87.4× Tenet Healthcare Corporation's market cap, and Tenet Healthcare Corporation is trading nearer its 52-week high, SpaceX nearer its low. Which is the better fit depends on your goals.
| SPCX | THC | |
|---|---|---|
Market Cap | $1.83T | $20.93B |
Sector | Technology | Health |
52-Week High | $202.09 | $262.63 |
52-Week Low | $108.27 | $161.37 |
Enterprise Value | $1.77T | $32.01B |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
SpaceX (SPCX) trades at $133.11, up 15.83% in 24 hours, reclaiming its $135 IPO price amid bullish technical signals and positive analyst sentiment. The stock shows strong momentum with resistance near $140 and support at $121. Despite negative profitability margins and high valuation ratios, robust revenue growth and significant capital investments in AI and infrastructure signal long-term ambition. Recent news highlights a major chip plant investment and a new satellite launch contract, fueling investor optimism.
Outlook is cautiously optimistic with a consensus price target of $228.52, though risks include persistent losses, high capex, and competitive pressures. The stock offers growth potential driven by Starlink's performance and strategic expansions, but investors must weigh volatility and execution risks against bullish analyst coverage.
Tenet Healthcare (THC) trades at $262.13, up 2.14% with strong technical momentum and bullish analyst sentiment. The stock shows robust fundamentals with Q2 2026 EPS beating estimates at $6.12 versus $4.26 expected, while valuation metrics remain attractive with P/E of 10.05 and EV/EBITDA of 5.74. Recent institutional buying and positive earnings revisions support the upward trend.
Outlook remains positive with consensus price target of $281.44 offering 7.4% upside potential. Key risks include healthcare policy headwinds and competitive pressures, but strong ambulatory growth and expense management provide fundamental support. The stock presents a compelling value-growth combination for investors seeking healthcare exposure.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About SpaceX
SpaceX is the world's leading aerospace manufacturer and launch provider. It designs and operates reusable rockets, spacecraft, and Starlink, a global satellite internet service with over 10 million subscribers across 160 countries.
Read more on SPCX →About Tenet Healthcare Corporation
Tenet Healthcare is a leading diversified healthcare services company that has strategically pivoted toward high-growth ambulatory care. Operating through United Surgical Partners International (USPI), the largest ambulatory platform in the U.S., Tenet manages an expansive network of surgical centers, acute care hospitals, and specialty facilities. The company’s focus on high-acuity services and operational efficiency, supported by its revenue cycle management subsidiary Conifer Health Solutions, positions it as a resilient leader in the evolving U.S. healthcare landscape.
Read more on THC →
